Woodrow D Anderson, Chief Accounting Officer at Indivior Pharmaceuticals, bought INDV on Aug 27, 2026
Data as of Oct 16
▲ BUY$53.5K1,500 shares at $35.69Woodrow D Anderson Chief Accounting OfficerINDV Indivior Pharmaceuticals, Inc.
- Traded
- Aug 27, 2026
- Disclosed
- Aug 27, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
INDV since disclosure
−8.1%
Similar stocks (XLV) since disclosure
+3.0%
XLV — its sector index fund
Change in closing price from Aug 27, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.